Cite
HARVARD Citation
Monjazeb, A. et al. (2015). Blocking indolamine 2, 3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Monjazeb, A. et al. (2015). Blocking indolamine 2, 3 dioxygenase mediated rebound immune suppression improves systemic anti-tumor effects of radio-immunotherapy. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].